India-based Bharat Serums and Vaccines (BSV) has entered into a definitive agreement to acquire Firstline Pharmaceuticals Sdn Bhd and Genomicks Sdn Bhd, to augment its presence in women’s health and reproductive therapy in Malaysia. 

Following the acquisition, the two companies will be held by BSV.  Incorporated in 2007, Firstline Pharmaceuticals Sdn Bhd is one of the leading distributors of fertility treatment in Malaysia. 

Genomicks Sdn Bhd was incorporated in 2016 and currently distributes medical devices in Malaysia.  The companies distribute a wide range of products which include Foliculin, Hucog, Humog, Profortil, Fortelle+Omega 3.

Speaking on the acquisition, Rahul Adakmol, COO-International Operations, BSV, said “Keeping women at the core of our business activities, we are committed to bringing our broad portfolio of treatment options, devices, and advanced fertility treatments, which deliver improved health outcomes and have a measurable impact on their wellbeing.”